Volume 17 - Issue 6 - June 2004

Practice Builders »

Exploring Compensation Options For A New Employee

By Steven Peltz, CHBC | 9800 reads | 0 comments

When you decide to hire a new podiatrist for your practice, one of the most important decisions you will face is deciding how much to pay your new hire. Ideally, you want to pay a base salary and offer an incentive that encourages the new podiatrist to work hard, pay for him- or herself quickly and then participate in the collections above his or her costs to the practice.
Potential employees are looking for compensation that will allow for a reasonable lifestyle along with loan payments. The challenge is how to take both of these concepts and create an agreement that is acceptable to each pa

Technology In Practice »

Is AmeriGel Care Lotion The Answer For Hydrating Dry Skin?

By Robi Garthwait, Contributing Editor | 6090 reads | 0 comments

While some patients may only see dehydrated feet as a minor nuisance, it can lead to further problems such as fungal infections and ulcerations. However, one emerging product can not only combat anhidrosis but may be helpful in treating a variety of skin problems, including psoriasis and icthyosis.
Podiatrists are turning to AmeriGel Care Lotion to solve an array of skin problems, citing its particular effectiveness with patients who have diabetes. The lotion, which contains Oakin™ or oak extract, is “the first and only antimicrobial, antifungal, antiinflammatory and antipruritic lotion

News and Trends »

New Studies Examine Potential Genetic Markers For Diabetes

By Brian McCurdy, Associate Editor | 5558 reads | 0 comments

Two new international studies reveal intriguing findings in the realm of diabetes research. In the Finland-United States Investigation of NIDDM Genetics (FUSION) study, which involved over 1,200 patients, researchers identified 10 single nucleotide polymorphisms (SNPs) that are associated with type 2 diabetes in the Finnish population. According to the study, which was published in a recent issue of Diabetes, these SNPs were located within or close to the hepatocyte nuclear factor 4 alpha (HNF4A) gene, which influences the expression of glucose metabolic genes.
In a separate study, whi

New Products »

Cooling Your Heels

3116 reads | 0 comments

A new cushion may help keep your patients’ heels cool and comfortable while speeding up the healing process.

For patients suffering from plantar fasciitis, the Sol Step provides cushioning and absorbs shock of the heel’s plantar aspect, according to the device’s manufacturer, Brown Medical. The company says the product’s neoprene stocking-like support offers a comfortable fit and the compression to the heel and arch accelerates healing.
Sol Step’s Sealed Ice pad cushions each foot. The company says the product can also provide up to 20 minutes of col

Point-Counterpoint »

Cryosurgery Or Sclerosing Injections: Which Is Better For Neuromas?

61854 reads | 0 comments

Cryogenic neuroablation is a safe, minimally invasive option that is less painful than alcohol injections and may facilitate a reduced risk of stump neuromas, according to this author.

By Lawrence Fallat, DPM

Morton’s neuroma (perineural fibroma) is a common painful forefoot disorder that can present treatment challenges to all podiatric physicians. The common digital nerves, usually in the second and third intermetatarsal spaces, become enlarged in the area of the deep transverse metatarsal ligament and subsequently cause pain in the ball of the foot with cramping, pain and num

Feature »

A Guide To Bracing For Charcot

By Jason Pollard, DPM, and Richard Stess, DPM | 35323 reads | 0 comments

Charcot neuroarthropathy is a progressive deterioration of a joint characterized by a loss of sensation. When left untreated, this condition can lead to pathological fractures, joint dislocation/subluxation and deformity. This condition reportedly affects an estimated 0.8 percent to 7.5 percent of people with diabetes. The prevalence of this condition increases dramatically among patients with diabetes and peripheral neuropathy, ranging from 29 to 35 percent in this specific population.1,2
However, this disorder is not limited to patients with diabetes as it can also afflict patien

  • « Previous
  •  | Page 1 of 3 | 
  • Next »